SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon - Quaterly Results

23 May 2023 Evaluate
A slight decline in the revenue of Rs. 5067.00 millions was seen for the March 2023 quarter as against Rs. 5177.00 millions during year-ago period.Net Profit for the quarter ended March 2023 zoomed to 4652.76% from Rs. 381.00 millions to Rs. 18108.00  millions.Operating profit for the quarter ended March 2023 decreased to 200.00 millions as compared to 873.00 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 5067.00 5177.00 -2.12 19929.00 17382.00 14.65 19929.00 17382.00 14.65
Other Income 640.00 608.00 5.26 2714.00 1872.00 44.98 2714.00 1872.00 44.98
PBIDT 200.00 873.00 -77.09 2949.00 2483.00 18.77 2949.00 2483.00 18.77
Interest 481.00 0.00 0.00 696.00 4.00 17300.00 696.00 4.00 17300.00
PBDT 18255.00 873.00 1991.07 30881.00 2479.00 1145.70 30881.00 2479.00 1145.70
Depreciation 294.00 281.00 4.63 1169.00 1082.00 8.04 1169.00 1082.00 8.04
PBT 17961.00 592.00 2933.95 29712.00 1397.00 2026.84 29712.00 1397.00 2026.84
TAX -147.00 211.00 -169.67 1228.00 536.00 129.10 1228.00 536.00 129.10
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 18108.00 381.00 4652.76 28484.00 861.00 3208.25 28484.00 861.00 3208.25
Equity 6003.00 6003.00 0.00 6003.00 6003.00 0.00 6003.00 6003.00 0.00
PBIDTM(%) 3.95 16.86 -76.59 14.80 14.28 3.59 14.80 14.28 3.59

Biocon Share Price

380.55 -2.05 (-0.54%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×